Funian Li
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cooperative Communication and Network Coding 10
-
- Advanced Wireless Communication Technologies 8
- Full-Duplex Wireless Communications 6
- Advanced MIMO Systems Optimization 2
- Co-authors
- Zhi‐Dong Lv (6 shared papers)Xiangping Liu (6 shared papers)Bin Kong (3 shared papers)Haibo Wang (4 shared papers)Qian Dong (2 shared papers)Weijun Zhao (1 shared paper)Xiaoyi Liu (5 shared papers)Weihong Cao (5 shared papers)
In The Last Decade
Funian Li
34 papers receiving 462 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 69
- Cancer Research 80
- Genetics 50
- Oncology 104
- Molecular Biology 215
Countries citing papers authored by Funian Li
This map shows the geographic impact of Funian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funian Li more than expected).
Fields of papers citing papers by Funian Li
This network shows the impact of papers produced by Funian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funian Li. The network helps show where Funian Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Funian Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. | 2014 | 116 |
| 2 | 2017 | 46 | |
| 3 | 2015 | 40 | |
| 4 | 2018 | 34 | |
| 5 | 2012 | 32 | |
| 6 | 2022 | 26 | |
| 7 | CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. | 2014 | 16 |
| 8 | 2013 | 15 | |
| 9 | 2021 | 15 | |
| 10 | NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma. | 2015 | 15 |
| 11 | 2012 | 13 | |
| 12 | 2019 | 12 | |
| 13 | 2013 | 11 | |
| 14 | 2020 | 10 | |
| 15 | 2011 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2018 | 7 | |
| 18 | 2011 | 7 | |
| 19 | [Effect of interleukin-18 gene modified human umbilical cord mesenchymal stem cells on proliferation of breast cancer cell]. | 2014 | 6 |
| 20 | PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells. | 2018 | 5 |
About Funian Li
Funian Li is a scholar working on Computer Networks and Communications, Electrical and Electronic Engineering, Molecular Biology, Oncology and Civil and Structural Engineering, having authored 40 papers that have together received 471 indexed citations. Recurring topics across this work include Cooperative Communication and Network Coding (10 papers), Advanced Wireless Communication Technologies (8 papers), Full-Duplex Wireless Communications (6 papers), Structural Health Monitoring Techniques (6 papers), Infrastructure Maintenance and Monitoring (4 papers), Immunotherapy and Immune Responses (3 papers), Advanced MIMO Systems Optimization (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Molecular Medicine (69 citations), Cancer Research (80 citations), Genetics (50 citations), Oncology (104 citations) and Molecular Biology (215 citations). Funian Li has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Zhi‐Dong Lv, Xiangping Liu, Bin Kong, Haibo Wang, Qian Dong, Weijun Zhao, Xiaoyi Liu, Weihong Cao, Xingang Wang and Jianxia Hu. Their work appears in journals such as Cellular Immunology, Brazilian Journal of Medical and Biological Research, Structural Control and Health Monitoring, Cellular Physiology and Biochemistry and International Journal of Sensor Networks.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.